Due Diligence Standards
Every company we represent passes comprehensive evaluation across six criteria:
• Management integrity and capability
• IP ownership and freedom to operate
• Financial sustainability and realistic capital needs
• Operational capability to execute the development timeline
• Clear regulatory pathway to FDA approval
• Ethical standards and genuine patient benefit
Companies that don’t meet these standards don’t advance. This protects both founders and investors.
About Benoît Lapointe
Ben spent five years as an investment advisor at RBC Dominion Securities in Toronto, where he learned to translate complex investment concepts for sophisticated clients and build portfolios managed by seasoned analysts.
For the past 20 years he has focused on connecting healthcare companies with the capital they need to reach patients. He has watched companies with proven treatments run out of money before commercialization. He has seen patients who needed those innovations never get access to them. That is the problem he solves.
He works with 3 to 5 companies at a time, takes equity in every engagement, and meets every prospective client in person before taking them on. His investor relationships span California, Canada, Europe, and the Middle East.
Ben holds a California real estate broker license and works selectively with established clients on confidential commercial real estate transactions